Ranitidine and Jadenu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine (ranitidine) and Jadenu (deferasirox). Common drug interactions include diarrhoea among females and nausea among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine and Jadenu. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

What is Jadenu?

Jadenu has active ingredients of deferasirox. eHealthMe is studying from 4,176 Jadenu users. Check the latest studies of Jadenu.

On Jul, 16, 2026

15 people who take Ranitidine and Jadenu together, and have interactions are studied.

Ranitidine and Jadenu drug interactions.

What are the common drug interactions of Ranitidine and Jadenu, by gender? *:

female:

Diarrhoea
Blood glucose increased
Blood iron increased
Cardiac murmur (an heart sound in valve abnormality)
Disease progression
Eye infection staphylococcal (staph eye infection are styes, large blisters in or around the eye, pain, swelling, and redness)
Faeces discoloured
Flatulence (flatus expelled through the anus)
Full blood count decreased
Haematochezia (passage of stools containing blood)

male:

Nausea (feeling of having an urge to vomit)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Hypoaesthesia (reduced sense of touch or sensation)
Malaise (a feeling of general discomfort or uneasiness)
Neck pain
Splenic infarction (tissue damage of spleen)
Arthralgia (joint pain)
Back pain
Blood pressure increased
Chest pain

What are the common drug interactions of Ranitidine and Jadenu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Arthralgia (joint pain)
Back pain
Blood pressure increased
Hyperhidrosis (abnormally increased sweating)
Nausea (feeling of having an urge to vomit)
Neck pain

20-29:

Pruritus (severe itching of the skin)
Pulmonary embolism (blockage of the main artery of the lung)

30-39:

Splenic infarction (tissue damage of spleen)

40-49:

n/a

50-59:

n/a

60+:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Chest pain
Colitis (inflammation of colon)
Diarrhoea
Disease progression
Hypoaesthesia (reduced sense of touch or sensation)
Nausea (feeling of having an urge to vomit)

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 26.67%
Iron Overload: 3 people, 20.00%
Anaemia (lack of blood): 2 people, 13.33%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 2 people, 13.33%
Stress And Anxiety: 1 person, 6.67%
Enlarged Prostate: 1 person, 6.67%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 6.67%
Arrhythmias (irregular heartbeat): 1 person, 6.67%
Colitis (inflammation of colon): 1 person, 6.67%
Diarrhea: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and Jadenu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously